Aimovig Pregnancy Exposure Registry
Public ClinicalTrials.gov record NCT06150781. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
GENESIS: AIMOVIG® Pregnancy Exposure Registry
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to estimate the proportion of major congenital malformations in infants of women with migraine exposed to erenumab-aooe during pregnancy compared to infants of women with migraine unexposed to erenumeb-aooe.
Study identification
- NCT ID
- NCT06150781
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 2,842 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2021
- Primary completion
- Oct 27, 2027
- Completion
- Oct 27, 2027
- Last update posted
- Nov 3, 2025
2021 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| IQVIA Virtual Site | Durham | North Carolina | 27703 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Migraine trials
Other public records listing Migraine. Sorted by last update posted; newest first. Not a recommendation.
- NCT07792291: Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life- Pilot Not yet recruiting
- NCT07764783: Visual Instillation of Sphenopalatine-block Intervention for ONgoing Migraine Not yet recruiting
- NCT05755945: A Study of Wearable Devices to Predict Migraines Active, not recruiting
- NCT07754266: Headache Ear Auditory Dizziness Sinus (HEADS) Registry Recruiting
- NCT07616128: Study of EVO756 in Adults With Migraine Recruiting
- NCT07645924: A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06150781, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 3, 2025 · Synced Jul 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06150781 live on ClinicalTrials.gov.